Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Transplant Proc ; 44(1): 150-3, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22310602

RESUMO

We have used low doses of mizoribine (MZ) or mycophenolate mofetil (MMF) as induction and maintenance immunosuppressants, but since 2009 have employed a high dose of MZ. We reviewed the efficacy and side effects of MZ compared with MMF. It is difficult to compare graft survivals between these periods because of different patient demographics, though the high dose of MZ cohort showed no significant difference from MMF. High doses of MZ serum to prevent acute rejection episodes as the induction and maintenance therapy. MZ controlled with blood concentrations showed less side effects, suggesting that high MZ doses could be safely used for an induction and maintenance antimetabolite.


Assuntos
Imunossupressores/administração & dosagem , Transplante de Rim , Ácido Micofenólico/análogos & derivados , Ribonucleosídeos/administração & dosagem , Adolescente , Adulto , Vírus BK/patogenicidade , Criança , Infecções por Citomegalovirus/virologia , Feminino , Rejeição de Enxerto/imunologia , Rejeição de Enxerto/prevenção & controle , Sobrevivência de Enxerto/efeitos dos fármacos , Herpes Zoster/virologia , Humanos , Imunossupressores/efeitos adversos , Imunossupressores/sangue , Imunossupressores/farmacocinética , Japão , Transplante de Rim/imunologia , Masculino , Pessoa de Meia-Idade , Ácido Micofenólico/administração & dosagem , Ácido Micofenólico/efeitos adversos , Infecções por Polyomavirus/virologia , Estudos Retrospectivos , Ribonucleosídeos/efeitos adversos , Ribonucleosídeos/sangue , Ribonucleosídeos/farmacocinética , Resultado do Tratamento , Adulto Jovem
2.
J Cardiol ; 28(5): 257-66, 1996 Nov.
Artigo em Japonês | MEDLINE | ID: mdl-8953399

RESUMO

The effects of nicorandil on coronary collateral circulation during exercise-induced ischemia were compared between the different donor arteries in 13 patients with effort angina, 7 with complete obstruction of the left anterior descending artery (LAD) with well-developed collateral vessels from the right coronary artery (RCA) (LAD group), and 6 with complete occlusion of the RCA (segment 2-3) with well-developed collateral vessels from the LAD (RCA group). Initial percentage thallium (%TI) uptake (thallium-201 single photon emission computed tomography) and washout rate were measured in the anterior, septal and posterior regions during ergometer exercise. The submaximal treadmill exercise test was also performed using a cardiopulmonary monitoring system to measure Vo2 at anaerobic threshold (AT). After the controls were obtained, nicorandil (15 mg/day) was administered for 4 weeks, during which ergometer exercise and treadmill exercise tests were carried out repeatedly. A significant improvement of initial %TI uptake on exercise was observed in the LAD group with nicorandil therapy, but no improvement was shown in the RCA group. The AT significantly increased after nicorandil treatment in the LAD group (13.9 +/- 0.38-->16.8 +/- 1.18 ml/min/kg), reflecting the improvement of cardiac function through the increased collateral flow. However, in the RCA group, it remained unchanged, suggesting no improvement of cardiac function. Nicorandil was effective to increase collateral flow from the RCA, but ineffective on that from the LAD. Nicorandil is an effective coronary dilator and is reported to affect both large and small coronary arteries. The effect on the collateral circulation is dependent on the donor artery supplying different areas. The vasodilator effect of nicorandil is mainly on the LAD, which is large enough to supply blood to a wider area of the heart, rather than the RCA.


Assuntos
Angina Pectoris/fisiopatologia , Circulação Coronária/efeitos dos fármacos , Niacinamida/análogos & derivados , Vasodilatadores/uso terapêutico , Adulto , Idoso , Angina Pectoris/tratamento farmacológico , Circulação Colateral/efeitos dos fármacos , Teste de Esforço , Feminino , Coração/diagnóstico por imagem , Hemodinâmica/efeitos dos fármacos , Humanos , Masculino , Pessoa de Meia-Idade , Niacinamida/farmacologia , Niacinamida/uso terapêutico , Nicorandil , Perfusão , Resistência Física , Radioisótopos de Tálio , Tomografia Computadorizada de Emissão de Fóton Único , Vasodilatadores/farmacologia
3.
Antimicrob Agents Chemother ; 39(9): 1979-83, 1995 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-8540702

RESUMO

We investigated the toxic effect of levofloxacin (LVFX), a quinolone antibacterial agent, on cartilage by examining aspects of its in vivo toxicokinetics and effect on the function of cultured chondrocytes of the femoral articular cartilage from juvenile New Zealand White rabbits. Repeated administration of LVFX (100 mg/kg) orally for 7 days induced focal necrosis and superficial erosion in the articular cartilage of the femoral condyle, but 30 mg/kg did not. Concentrations of LVFX in the cartilage were highest at the first sampling point (30 min) after a single administration, being 4.93 and 12.2 micrograms/g in the 30- and 100-mg/kg groups, respectively. The arthropathic concentration of LVFX in the cartilage was then shown to be 12.2 micrograms/g or more. For an in vitro study, chondrocytes were separated from the articular cartilage of the rabbit femoral condyle and cultured for 7 days until confluence. 35SO4 uptake by cultured chondrocyte sheets was most susceptible to LVFX, decreasing at drug concentrations of 5 micrograms/ml or more in 24- and 48-h cultures but not in a 72-h culture. Furthermore, 3H-thymidine uptake was decreased at concentrations of 10 micrograms/ml or more in a 48-h culture but not in 24- and 72-h cultures. Rhodamine 123 accumulation was susceptible to inhibition in cultured chondrocytes at an LVFX concentration of 10 micrograms/ml or more. These results suggest that LVFX inhibits glycosaminoglycan synthesis initially and DNA synthesis and mitochondrial function secondarily at actual arthropathic concentrations in cultured rabbit chondrocytes but that these changes are reversible and not enough to kill the cells.


Assuntos
Anti-Infecciosos/toxicidade , Cartilagem Articular/metabolismo , DNA/biossíntese , Glicosaminoglicanos/biossíntese , Levofloxacino , Ofloxacino/toxicidade , Animais , Anti-Infecciosos/farmacocinética , Cartilagem Articular/citologia , Cartilagem Articular/lesões , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Masculino , Ofloxacino/farmacocinética , Coelhos , Sulfatos/metabolismo , Radioisótopos de Enxofre , Timidina/metabolismo
4.
Nihon Shokakibyo Gakkai Zasshi ; 86(7): 1448-54, 1989 Jul.
Artigo em Japonês | MEDLINE | ID: mdl-2810851

RESUMO

We attempted to clarify the association between HLA and Crohn's disease. HLA-A, -B, -C, -DR and -DQ locus antigens in 108 Japanese patients with Crohn's disease were analyzed and the results were compared with findings of 472 healthy Japanese. In patients with Crohn's disease there was a strong positive association with HLA-DR4 (chi 2 = 14.086, Pc less than 0.005, RR = 2.231), and a weak positive association with HLA-B51, -Bw54, -DRw12, -DRw13 and -DRw52. While there was a strong negative association with HLA-DR2 (chi 2 = 10.194, Pc less than 0.025, RR = 0.435), DQw1 (chi 2 = 14.680, Pc less than 0.001 RR = 0.442) and DQw3 (chi 2 = 7.760 Pc less than 0.025 RR = 0.549), and a weak negative association with HLA-B7. In conclusion, susceptibility to Crohn's disease may relate to HLA-DR4, especially HLA-DR4.1, in Japanese patients.


Assuntos
Doença de Crohn/imunologia , Antígenos HLA/análise , Adolescente , Adulto , Doença de Crohn/etnologia , Suscetibilidade a Doenças , Feminino , Antígeno HLA-DR4/análise , Humanos , Japão , Masculino
6.
Kaibogaku Zasshi ; 43(6): 431-2, 1968 Dec 01.
Artigo em Japonês | MEDLINE | ID: mdl-4886402
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...